Prior to this several other anti-obesity drugs had also proven disappointing due to adverse effects such as cardiovascular problems, increased suicidal risk and enhanced drug dependence and abuse (Mller, Blher, Tschp, DiMarchi)
Coverage for weight loss alone may be more limited or denied, depending on the plan
For people with IBS, this raises an important question: what happens when a medication designed to slow gut motility meets an already sensitive gut
The reality is that obesity and weight gain are not just matters of willpowerthey are complex medical conditions influenced by genetics, hormones, and metabolic adaptation
Only real results that last
One such innovative treatment we provide is Ozempic, a GLP-1 receptor agonist initially developed to help individuals with Type 2 diabetes manage their blood sugar